1. Chemokine changes during direct antiviral agents (DAA) therapy in patients with HCV infection or reinfection after liver transplantation: preliminary insights on their possible correlates. (February 2019) Authors: Colucci, G.; Donato, M.F.; D'Ambrosio, R.; Invernizzi, F.; Degasperi, E.; Perbellini, R.; Lunghi, G.; Uceda, S.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early recurrence of hepatocellular carcinoma after liver transplantation can be predicted by fdg-pet and microvascular invasion at explant pathology. (February 2020) Authors: Iavarone, M.; Invernizzi, F.; Dondossola, D.; De Monti, A.; Mazza, S.; Maggi, U.; Antonelli, B.; De Feo, T.; Florimonte, L.; Lampertico, P.; Rossi, G.; Donato, M.F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival. (February 2019) Authors: Mazza, S.; Invernizzi, F.; Iavarone, M.; Zavaglia, C.; Maggi, U.; Cesarini, L.; Antonelli, B.; Airoldi, A.; Manini, M.A.; Sangiovanni, A.; Rossi, G.; Donato, M.F.; Belli, L.S.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival. Issue 1 (February 2018) Authors: Invernizzi, F.; Iavarone, M.; Donato, M.F.; Sangiovanni, A.; Monico, S.; Manini, M.A.; Maggi, U.; Antonelli, B.; Dondossola, D.; Rossi, G.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness and safety of DAA treatment for recurrent hepatitis C after liver transplantation: The NAVIGATOR Lombardia-Veneto network. Issue 1 (February 2018) Authors: Invernizzi, F.; Pasulo, L.; Aghemo, A.; Puoti, M.; Zaltron, S.; Maggiolo, F.; Rizzardini, G.; Fargion, S.; Sacchi, P.; Gulminetti, R.; Zuin, M.; Quirino, T.; Rumi, M.G.; Pan, A.; Grossi, P.; Rossini, A.; Corbellini, A.; Uberti Foppa, C.; Belli, L.; Piovesan, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Energy harvesting from human motion: materials and techniques. (11th July 2016) Authors: Invernizzi, F.; Dulio, S.; Patrini, M.; Guizzetti, G.; Mustarelli, P. Journal: Chemical Society reviews Issue: Volume 45:Number 20(2016:Oct.) Page Start: 5455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epidemiology, features and outcomes of patients transplanted for hepatocellular carcinoma in the last decade: a single center experience. (February 2020) Authors: Invernizzi, F.; Iavarone, M.; Dondossola, D.; Antonelli, B.; Zefilippo, A.; De Feo, T.; Maggioni, M.; Sangiovanni, A.; Lampertico, P.; Rossi, G.; Donato, M.F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hepatocellular carcinoma developing in European patients with prolonged HBV suppression: Biological and clinical features, and outcome. (10th February 2016) Authors: Lampertico, P.; Grossi, G.; Loglio, A.; Viganò, M.; Facchetti, F.; Invernizzi, F.; Iavarone, M.; Sangiovanni, A.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HLA DPB1 rs9277535 polymorphism strongly predicts HBsAg clearance in interferon treated genotype D HBeAg-negative patients with chronic hepatitis B. (15th February 2015) Authors: Lampertico, P.; Galmozzi, E.; Facchetti, F.; Cheroni, C.; Invernizzi, F.; Valveri, V.; Soffredini, R.; Viganò, M.; Abrignani, S.; De Francesco, R.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients. (15th February 2015) Authors: Galmozzi, E.; Lampertico, P.; Facchetti, F.; Invernizzi, F.; Mangia, G.; Vigano, M.; Soffredini, R.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗